SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.27 |
| Enterprise Value ($M) | 5.74 |
| Book Value ($M) | 0.83 |
| Book Value / Share | 0.31 |
| Price / Book | 3.96 |
| NCAV ($M) | 0.83 |
| NCAV / Share | 0.31 |
| Price / NCAV | 3.96 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -4.33 |
| Return on Assets (ROA) | -1.00 |
| Return on Equity (ROE) | -1.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.60 |
| Current Ratio | 3.60 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1.15 |
| Assets | 1.15 |
| Liabilities | 0.32 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -3.57 |
| Net Income | -3.59 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -3.16 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Intracoastal Capital, Llc | 4.99 | ||
| 13G/A | Orca Capital AG | 4.50 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 204 | 425 | 48.00 | |
| 398 | 3,720 | 10.70 | |
| 199 | 4,498 | 4.42 | |
| 178 | 1,081 | 16.47 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LFVN – LifeVantage Corporation | LGVN – Longeveron Inc. |
| LIPO – Lipella Pharmaceuticals Inc. | LPCN – Lipocine Inc. |
| LPTX – Leap Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io